对TgGSK3的结构和功能表征,TgGSK3是一种Toxoplasma gondii中的可药物酶
Silvia Diaz-Martin1, Christopher Swale1, Valeria Bellini1
1Institute for Advanced Biosciences (IAB), Team Host-pathogen interactions and immunity to infection, INSERM U1209, CNRS UMR5309, University Grenoble Alpes, Grenoble, France.
Nature communications
|November 5, 2025
概括
一个药物重定向屏幕确定了LY2090314作为毒素菌和Cryptosporidium的强有力的抑制剂. 这项研究揭示了TgGSK3激酶是主要的分子标,为这些杂寄生虫提供了有前途的治疗途径.
科学领域:
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
- 结构生物学 结构生物学
背景情况:
- 猿类复合体寄生虫Toxoplasma gondii和Cryptosporidium给我们的健康带来了重大挑战.
- 目前用于毒素菌和密码菌的治疗方法在有效性和副作用方面存在局限性.
- 治疗选择有限,特别是在密码化症.
研究的目的:
- 通过药物重新定位来确定治疗复合体感染的新型治疗剂.
- 阐明已识别的候选药物的分子作用机制.
- 为了验证TgGSK3激酶作为潜在的治疗点.
主要方法:
- 对FDA批准的药物库对Toxoplasma进行表型查.
- 使用前进遗传学,转录组测序和计算突变分析的目标解卷.
- 进行X射线晶体学以确定与TgGSK3.3结合的LY2090314的结构.
- 相互作用组分析以了解TgGSK3的功能连接.
主要成果:
- LY2090314被确定为T. gondii和Cryptosporidium生长的强有力的抑制剂.
- 证实TgGSK3激酶是LY2090314.4的主要分子标.
- X射线晶体结构显示LY2090314是一种I型ATP竞争性抑制剂.
- 发现了TgGSK3与关键细胞调节体之间的功能联系.
结论:
- TgGSK3激酶是已验证的毒素菌治疗标.
- LY2090314代表了一种有前途的化合物,用于治疗复合体感染.
- 提供了对复合体GSK3生物学的机制性见解.
更多相关视频
相关概念视频
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transgenic Organisms
Overview
GTPases and their Regulation
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Large G-proteins, also known...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:


